Skip to main content
ByMay 27, 2026~9 min read

Golan Industries in the First Quarter: Working Capital Freed Cash, Margins Still Deteriorated

Golan Industries opened 2026 with operating cash flow of NIS 22.3 million, but the operating read was much weaker: revenue declined, gross margin compressed and operating profit nearly disappeared. The quarter shifts the question from whether the company can release cash to whether it can do so without losing margins and adding more fixed obligations.

Golan Industries gave a partial answer in the first quarter to the issue that weighed on 2025: cash came back, but not yet in a way that cleans up the story. Operating cash flow reached NIS 22.3 million, compared with NIS 8.5 million in the parallel quarter and only NIS 5.3 million in all of 2025. That is a real change. The problem is that the cash release sits next to a much weaker operating quarter: revenue fell 3.9%, gross margin dropped to 22.9%, and operating profit shrank to only NIS 1.1 million. The quarter therefore does not prove a full recovery. It moves the test to a sharper place: whether lower receivables and higher accrued payables are the beginning of a working-capital repair, or mostly favorable timing against weaker margins. At the same time, the company paid a NIS 6 million dividend in January and declared another NIS 4.5 million dividend in March, while lease liabilities nearly doubled after the lease extension with Kibbutz Sha'ar Hagolan and new lease contracts in the U.S. The next quarters need to show that cash is coming from a business that can sell, hold price and fund expansion, not only from a one-quarter receivables release.

Company Map

Golan Industries manufactures cross-linked polyethylene, PEX, piping systems and multilayer pipes for heating and plumbing systems. Its economics are not only a simple industrial volume story. The company earns well when it can protect price, product mix, production efficiency and customer credit across markets tied to construction, infrastructure, mining and industry.

The quarter's business map is straightforward. Israel is still the core, with NIS 64.6 million in revenue, about 68% of group revenue. Europe contributed NIS 20.6 million, Latin America NIS 4.5 million, and other markets NIS 5.1 million. By product, Pexgol held almost flat at NIS 73.0 million versus NIS 73.1 million in the parallel quarter. Multigol, by contrast, fell from NIS 25.5 million to NIS 21.7 million, mainly in Israel.

In the 2025 annual analysis, the test was whether the recovery in Israel would also move into collections, inventory and cash flow, rather than staying only in sales. The first quarter closes part of that question, but not with a clean positive answer. Cash flow improved, but Israel declined 4%, the local segment lost almost half of its segment profit, and financing became heavier. The cash improvement did not arrive together with better earnings quality.

A Small Revenue Decline Hid a Much Larger Margin Problem

The simple headline could have been a revenue decline of about 4%. That is not the important number. The issue is that revenue fell slightly while cost of sales rose 2.1%, cutting gross profit by 19.9%. Gross margin fell from 27.5% to 22.9%, and operating profit dropped from NIS 6.7 million to NIS 1.1 million. In one quarter, the company moved from a 6.8% operating margin to 1.2%.

Revenue slipped slightly, operating profit fell sharply

The segment table explains why this was not only a broad slowdown. Israel fell from NIS 66.9 million to NIS 64.6 million, but segment profit dropped from NIS 13.2 million to NIS 7.1 million. Latin America fell from NIS 9.1 million in revenue to NIS 4.5 million, and segment profit declined from NIS 3.4 million to NIS 1.2 million. Europe improved modestly and moved from a segment loss to a small profit, while other markets grew. Those improvements were not enough to hold up the group.

The security event the company calls Operation Lion's Roar explains part of the pressure in Israel: project delays, movement restrictions, labor shortages, logistics disruption and increases in raw material, energy and FX costs. But that explanation does not make the quarter cleaner. It sharpens the concentration risk. About 68% of sales came from Israel, and about 75% of Israeli sales came from construction. When that market stalls even temporarily, the company feels it in both revenue and margin.

Cash Flow Improved, But Not All of It Is Recurring Operating Strength

Operating cash flow is the clear positive number in the quarter. The company moved from NIS 8.5 million in the parallel quarter to NIS 22.3 million in the current quarter. Here the distinction matters: this was all-in cash flexibility after working-capital movement, not proof of stronger normalized cash generation. In this quarter, the cash flexibility was built mainly from lower receivables and higher payables, not from higher profitability.

How a net loss became positive operating cash flow

The decline in customers contributed NIS 11.1 million to cash flow, and the increase in accrued payables contributed another NIS 12.2 million. Inventory still consumed NIS 1.6 million, and other receivables consumed NIS 2.0 million. So the company did release cash, but it has not yet proved that the business is generating more cash from ordinary activity. The income statement and the cash statement are pulling in opposite directions: a net loss on one side, strong operating cash flow on the other.

After all cash uses, the position is reasonable but not unconstrained. The company generated NIS 22.3 million from operations, invested NIS 7.5 million, and used NIS 10.6 million in financing activities, including the NIS 6 million dividend paid in January, NIS 2.8 million of lease repayment and net short-term credit repayment. Cash rose by NIS 4.1 million to NIS 14.6 million, alongside short-term investments of NIS 15.8 million. This is not liquidity stress, but it is also not proof of a new cash-generating run-rate.

The dividend adds another check. The company paid NIS 6 million in January and declared an additional NIS 4.5 million dividend for June. Against positive quarterly cash flow that is possible. Against a net loss, NIS 1.1 million of operating profit and higher lease liabilities, it requires the next quarters to show real margin recovery and not only a temporary receivables release.

Two balance-sheet movements matter more than the revenue headline. The first is leases. Right-of-use assets jumped from NIS 50.0 million at the end of 2025 to NIS 103.4 million at the end of March, and lease liabilities rose from NIS 55.0 million to NIS 108.5 million. The main reason was the ten-year lease extension with Kibbutz Sha'ar Hagolan and new lease contracts at a U.S. subsidiary.

In the prior article on dependence on Kibbutz Sha'ar Hagolan, the extension was framed as a move that removed a near-term operating risk but preserved dependence on a site the company does not own. The current quarter adds the number: the operating solution increased right-of-use assets and future lease obligations. This is not bank debt, and the company's bank credit still does not require financial covenants. Still, for an industrial company whose margin is under pressure, another fixed obligation raises sensitivity to weak quarters.

The second movement is Wizsol. The company increased its holding from 31.9% to 100% after a separation agreement among the shareholders, with no direct consideration for the shares and after converting a loan of about NIS 2.5 million into equity. As a result, the company recognized intangible assets of NIS 3.45 million and a NIS 577 thousand loss from the deemed disposal of its prior holding. It is a small move relative to the group, but it shows the company is still collecting activities and assets around the core even in a quarter when the core activity was weak.

Latin America is the clearer negative signal. Crosspipe, the jointly controlled company in Chile, reported quarterly revenue of NIS 7.4 million versus NIS 12.4 million in the parallel quarter, and net profit fell from NIS 3.6 million to NIS 0.7 million. The company's share of Crosspipe's profit fell from NIS 1.8 million to NIS 0.3 million. In the consolidated company's segment figures, Latin America declined sharply in both revenue and segment profit. A future improvement outside Israel is still not proven, even if Europe and other markets showed positive points.

The North American move also still needs proof. The U.S. subsidiary and Sioux Chief established a joint corporation at the end of 2025 to manufacture and market residential PEX piping in the U.S. and Canada. In the first quarter, there is no disclosure that allows investors to isolate revenue, backlog, utilization or profitability from that venture. As long as that remains the case, the U.S. investments and leases are strategic optionality, not yet a measurable profit engine.

Conclusions

The first quarter does not put the company back on a clean recovery path, but it is not only a weak quarter either. It shows that the company can release cash from the balance sheet, keep a current ratio of 2.2 and maintain bank credit without financial covenants. Against that, operating profitability nearly disappeared, net finance expenses rose to NIS 2.3 million, Latin America weakened, and lease liabilities almost doubled.

That makes 2026 a proof year, not a breakout year. For the read to improve, the next quarters need to show three things: recovery in gross and operating margins, operating cash flow that relies less on lower receivables and higher accrued payables, and a clearer commercial signal from the U.S. activity or from markets outside Israel. The counter-thesis is that the quarter absorbed a security event, price volatility and temporary weakness in Chile, so the strong cash flow may be the beginning of a repair rather than only timing. The turning point is straightforward: if revenue resumes growth, gross margin moves back toward the stronger levels seen earlier in 2025, and cash stays positive without an unusual receivables release, the first quarter will look like a trough. If not, the market will focus less on the product base and new ventures, and more on whether the company can fund expansion and dividends while the operating core remains weak.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction